We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.34B
AUM Growth
–
Cap. Flow
+$4.36B
Cap. Flow %
81.59%
Top 10 Hldgs %
16.76%
Holding
517
New
456
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0 quarters
Top 10 Avg Time Held Equity + Options
0 quarters
Top 20 Avg Time Held Equity + Options
0 quarters
Avg Time Held Equity only
0 quarters
Top 10 Avg Time Held Equity only
0 quarters
Top 20 Avg Time Held Equity only
0 quarters

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.34%
2 Consumer Staples 15.45%
3 Real Estate 13.97%
4 Consumer Discretionary 7.8%
5 Healthcare 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FST
351
DELISTED
FOREST OIL CORPORATION
FST
$468K 0.01%
+114,497
New +$521K
2013 Q2
0 quarters
TWER
352
DELISTED
Towerstream Corporation Common Stock
TWER
$459K 0.01%
+9,000
New +$426K
2013 Q2
0 quarters
EARN icon
353
Ellington Residential Mortgage REIT
EARN
$128M
$446K 0.01%
+25,000
New +$467K
2013 Q2
0 quarters
MRSH icon
354
Marsh
MRSH
$83.9B
$445K 0.01%
+11,154
New +$436K
2013 Q2
0 quarters
DXJ icon
355
CALL
WisdomTree Japan Hedged Equity Fund
DXJ
$2.38B
$430K 0.01%
+600,000
New +$9.34M
2013 Q2
0 quarters
SSNC icon
356
SS&C Technologies
SSNC
$19B
$429K 0.01%
+26,066
New +$406K
2013 Q2
0 quarters
UNG icon
357
United States Natural Gas Fund
UNG
$522M
$428K 0.01%
+1,412
New +$490K
2013 Q2
0 quarters
ACHN
358
DELISTED
Achillion Pharmaceuticals
ACHN
$417K 0.01%
+51,000
New +$389K
2013 Q2
0 quarters
SWKS icon
359
Skyworks Solutions
SWKS
$11.5B
$416K 0.01%
+19,016
New +$421K
2013 Q2
0 quarters
IMRS
360
DELISTED
IMRIS INC COMMON SHARES (CANADA)
IMRS
$414K 0.01%
+150,000
New +$413K
2013 Q2
0 quarters
NKE icon
361
CALL
Nike
NKE
$51.6B
$407K 0.01%
+206,200
New +$6.41M
2013 Q2
0 quarters
RVTY icon
362
Revvity
RVTY
$17.2B
$397K 0.01%
+12,212
New +$400K
2013 Q2
0 quarters
ANAD
363
DELISTED
ANADIGICS INC
ANAD
$396K 0.01%
+180,000
New +$360K
2013 Q2
0 quarters
KBIO
364
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$393K 0.01%
+8,672
New +$393K
2013 Q2
0 quarters
IYR icon
365
CALL
iShares US Real Estate ETF
IYR
$4.16B
$392K 0.01%
+450,000
New +$31.8M
2013 Q2
0 quarters
EQIX icon
366
CALL
Equinix
EQIX
$101B
$388K 0.01%
+78,600
New +$16.3M
2013 Q2
0 quarters
SRCI
367
DELISTED
SRC Energy Inc
SRCI
$366K 0.01%
+50,000
New +$340K
2013 Q2
0 quarters
DVAX icon
368
DELISTED
Dynavax Technologies
DVAX
$362K 0.01%
+32,910
New +$693K
2013 Q2
0 quarters
PEP icon
369
PepsiCo
PEP
$172B
$360K 0.01%
+4,397
New +$359K
2013 Q2
0 quarters
PALL icon
370
abrdn Physical Palladium Shares ETF
PALL
$606M
$349K 0.01%
+27,000
New +$378K
2013 Q2
0 quarters
AFG icon
371
American Financial Group
AFG
$11.7B
$346K 0.01%
+7,076
New +$341K
2013 Q2
0 quarters
SVRA icon
372
Savara
SVRA
$1.01B
$341K 0.01%
+11,356
New +$504K
2013 Q2
0 quarters
GWPH
373
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$304K 0.01%
+35,060
New +$310K
2013 Q2
0 quarters
MNKD icon
374
CALL
MannKind Corp
MNKD
$1.06B
$302K 0.01%
+20,000
New +$536K
2013 Q2
0 quarters
CAT icon
375
PUT
Caterpillar
CAT
$368B
$300K 0.01%
+115,000
New +$9.78M
2013 Q2
0 quarters

Similar funds

UBS O'Connor's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for UBS O'Connor, which disclosed 517 positions worth $5.34B. Its ten largest holdings account for 17% of the portfolio.

Its largest position is Pfizer: 6,269,077 shares worth $167M.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, followed by Consumer Staples and Real Estate.

  • UBS O'Connor's largest Q2 2013 buy was Pfizer: 6,269,077 shares worth $167M.
  • UBS O'Connor's ten largest holdings make up 17% of its $5.34B portfolio in Q2 2013.
  • UBS O'Connor disclosed 517 positions in Q2 2013, its first 13F filing on record.

Based on UBS O'Connor's 13F filing for Q2 2013, filed 13 Aug 2013.